Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia

Summary

The investigator's goal in this study is to evaluate the efficacy and safety of nebulized amikacin versus intravenous amikacin in patients with hospital and ventilator acquired pneumonia in surgical patients admitted to the intensive care units infected with gram negative bacilli

Timeline

Start

2014-08

Primary completion

2015-08

Completion

2015-08

Drugs

Indications